188 related articles for article (PubMed ID: 22305713)
1. Third trimester fetal pulmonary artery Doppler blood flow velocity characteristics following prenatal selective serotonin reuptake inhibitor (SSRI) exposure.
Lim K; Sanders A; Brain U; Riggs W; Oberlander TF; Rurak D
Early Hum Dev; 2012 Aug; 88(8):609-15. PubMed ID: 22305713
[TBL] [Abstract][Full Text] [Related]
2. Third trimester fetal heart rate and Doppler middle cerebral artery blood flow velocity characteristics during prenatal selective serotonin reuptake inhibitor exposure.
Rurak D; Lim K; Sanders A; Brain U; Riggs W; Oberlander TF
Pediatr Res; 2011 Jul; 70(1):96-101. PubMed ID: 21436759
[TBL] [Abstract][Full Text] [Related]
3. Blood flow velocity waveforms of the fetal pulmonary artery and the ductus arteriosus: reference ranges from 13 weeks to term.
Mielke G; Benda N
Ultrasound Obstet Gynecol; 2000 Mar; 15(3):213-8. PubMed ID: 10846777
[TBL] [Abstract][Full Text] [Related]
4. Fetal branch pulmonary arterial vascular impedance during the second half of pregnancy.
Rasanen J; Huhta JC; Weiner S; Wood DC; Ludomirski A
Am J Obstet Gynecol; 1996 May; 174(5):1441-9. PubMed ID: 9065109
[TBL] [Abstract][Full Text] [Related]
5. Fetal pulmonary artery Doppler blood flow velocity measures and early infant lung function. A prospective cohort study.
Hilde K; Gudmundsdóttir HK; Stensby Bains KE; Färdig M; Lødrup Carlsen KC; Jonassen CM; Kreyberg I; Nordlund B; Rehbinder EM; Paasche Roland MC; Skjerven HO; Staff AC; Vettukattil R; Haugen G
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2213796. PubMed ID: 37197978
[TBL] [Abstract][Full Text] [Related]
6. Improvement in fetal pulmonary hypertension and maturity after reversal of ductal constriction: prospective cohort study.
Zielinsky P; MagalhÃes GA; Zurita-Peralta J; Sosa-OlavarrÍa A; Marinho G; Van Der Sand L; Sulis NM; Nicoloso LH; Piccoli A; Vian I
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):420-427. PubMed ID: 33502049
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
[TBL] [Abstract][Full Text] [Related]
8. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
[TBL] [Abstract][Full Text] [Related]
10. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
Chambers CD; Hernandez-Diaz S; Van Marter LJ; Werler MM; Louik C; Jones KL; Mitchell AA
N Engl J Med; 2006 Feb; 354(6):579-87. PubMed ID: 16467545
[TBL] [Abstract][Full Text] [Related]
12. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
13. Doppler velocimetry in branch pulmonary arteries of normal human fetuses during the second half of gestation.
Laudy JA; de Ridder MA; Wladimiroff JW
Pediatr Res; 1997 Jun; 41(6):897-901. PubMed ID: 9167205
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
15. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.
Andrade SE; McPhillips H; Loren D; Raebel MA; Lane K; Livingston J; Boudreau DM; Smith DH; Davis RL; Willy ME; Platt R
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):246-52. PubMed ID: 19148882
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of the human fetal pulmonary circulation to maternal hyperoxygenation increases during the second half of pregnancy: a randomized study.
Rasanen J; Wood DC; Debbs RH; Cohen J; Weiner S; Huhta JC
Circulation; 1998 Jan; 97(3):257-62. PubMed ID: 9462527
[TBL] [Abstract][Full Text] [Related]
18. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of midtrimester ductus venosus diameter and peak systolic velocity to predict late onset small for gestational age fetuses.
Eraslan Sahin M; Sahin E; Col Madendag I; Madendag Y; Acmaz G; Ozdemir F; Kırlangıç MM; Muderris II
J Matern Fetal Neonatal Med; 2022 Oct; 35(20):3984-3990. PubMed ID: 33190543
[TBL] [Abstract][Full Text] [Related]
20. Umbilical artery pulsatility index and half-peak systolic velocity deceleration time in fetuses with trisomy 21.
Bustos JC; Herrera A; Sepulveda W
J Matern Fetal Neonatal Med; 2020 Oct; 33(20):3469-3475. PubMed ID: 30741044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
